| Structure, properties, and biological relevance of the DNA and RNA G-quadruplexes: Overview 50 years after their discovery NG Dolinnaya, AM Ogloblina, MG Yakubovskaya Biochemistry (Moscow) 81, 1602-1649, 2016 | 102 | 2016 |
| Transcription blockage by stable H-DNA analogs in vitro S Pandey, AM Ogloblina, BP Belotserkovskii, NG Dolinnaya, ... Nucleic Acids Research 43 (14), 6994-7004, 2015 | 33 | 2015 |
| Parallel G-quadruplexes formed by guanine-rich microsatellite repeats inhibit human topoisomerase I AM Ogloblina, VA Bannikova, AN Khristich, TS Oretskaya, ... Biochemistry (Moscow) 80, 1026-1038, 2015 | 30 | 2015 |
| Multi-targeted effects of G4-aptamers and their antiproliferative activity against cancer cells AM Ogloblina, AN Khristich, NY Karpechenko, SE Semina, GA Belitsky, ... Biochimie 145, 163-173, 2018 | 24 | 2018 |
| Responses of DNA mismatch repair proteins to a stable G-quadruplex embedded into a DNA duplex structure AV Pavlova, MV Monakhova, AM Ogloblina, NA Andreeva, GY Laptev, ... International Journal of Molecular Sciences 21 (22), 8773, 2020 | 19 | 2020 |
| Toward G-quadruplex-based anticancer agents: biophysical and biological studies of novel AS1411 derivatives AM Ogloblina, N Iaccarino, D Capasso, S Di Gaetano, EU Garzarella, ... International Journal of Molecular Sciences 21 (20), 7781, 2020 | 16 | 2020 |
| Effects of G-quadruplex-binding plant secondary metabolites on c-MYC expression RG Zenkov, KI Kirsanov, AM Ogloblina, OA Vlasova, DS Naberezhnov, ... International Journal of Molecular Sciences 23 (16), 9209, 2022 | 14 | 2022 |
| RNA sequencing as a confirmatory assay and its impact on patient care in multiple cancer types. PM Kasi, S Smirnova, V Nikulin, JH Brown, N Almog, A Ogloblina, C Yam, ... Journal of Clinical Oncology 41 (16_suppl), e15058-e15058, 2023 | 1 | 2023 |
| Integrated single-cell spatial multi-omics of intratumor heterogeneity in renal cell carcinoma. JJ Hsieh, N Miheecheva, A Ramachandran, Y Lyu, I Galkin, V Svekolkin, ... Journal of Clinical Oncology 38 (15_suppl), e17106-e17106, 2020 | 1 | 2020 |
| 183 Comprehensive molecular profiling in the management of patients with diverse sarcoma subtypes A Tarasov, V Kushnarev, A Khachatryan, K Kryukov, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
| MO60-3 Aggregated analysis of integrated whole exome (WES) and whole transcriptome (WTS) sequencing in 1,000 cancer patients K Chernyshov, A Love, K Rumyantsev, V Senichkin, G Sagaradze, ... Annals of Oncology 35, S1360, 2024 | | 2024 |
| Tumor immunity portrait: An AI-driven molecular predictor combining tumor microenvironment and tumor mutational burden for immune checkpoint inhibitor response prediction. P Shilo, A Tarasov, A Filatova, K Danilov, I Valiev, N Kotlov, JH Brown, ... Journal of Clinical Oncology 41 (16_suppl), e14691-e14691, 2023 | | 2023 |
| Aggregated analysis of 1,000 patients with cancer to assess the benefits of integrated whole exome and whole transcriptome sequencing. K Chernyshov, A Love, V Senichkin, G Sagaradze, K Rumyantsev, ... Journal of Clinical Oncology 41 (16_suppl), 3076-3076, 2023 | | 2023 |
| Integrated-omics of MRI-visible and-invisible prostate cancer identifies molecular correlations with clinical outcome. E Kim, N Miheecheva, A Ramachandran, Y Lyu, I Galkin, V Svekolkin, ... Journal of Clinical Oncology 38 (15_suppl), e17506-e17506, 2020 | | 2020 |
| T25: Selective glucocorticoid receptor agonists as novel anti-cancer agents E Lesovaya, L Tilova, O Zadorozhnaya, A Savinkova, K Kirsanov, ... European Journal of Cancer Supplements 13 (1), 33-34, 2015 | | 2015 |
| P85: Synthesis and anti-cancer effects of CpdA enantiomers, non-steroidal glucocorticoid receptor ligands L Tilova, O Zadorozhnaya, A Savinkova, K Kirsanov, A Ogloblina, ... European Journal of Cancer Supplements 13 (1), 61-62, 2015 | | 2015 |
